Avtal | $24,000,000 | (Mar 20, 2026)
games2gether | $5,202,945 | (Mar 20, 2026)
Claros | $30,000,000 | (Mar 20, 2026)
Sigrid Therapeutics AB
Sweden
- Stockholm
- 20/01/2023
- Unknown
- $580,679
Lifestyle diseases, caused by poor diet and physical inactivity among others, are rising worldwide. Each year 70% of all deaths globally – 40 million – are attributed to lifestyle diseases such as obesity, type 2 diabetes and heart disease.
Sigrid is a clinical-stage biotech company driven by the vision to improve human health through material-based innovations. We are pioneering a new class of engineered materials to prevent and treat lifestyle disease more safely and effectively.
- Industry Medical Equipment Manufacturing
- Website https://www.sigridthx.com/
- LinkedIn https://www.linkedin.com/company/sigrid-therapeutics-ab/
Related People
Sana AlajmovicCo Founder
Sweden -
Greater Stockholm Metropolitan Area
Entrepreneur with a demonstrated history of working in the biotechnology industry. Skilled in Business Planning, Operations Management, Sales, Entrepreneurship, and International Business. Strong business development professional with a BSc Program in Business and Economcis focused in Economics and Marketing from Stockholm School of Economics.
Latent | $80,000,000 | (Mar 20, 2026)
Corridor | $25,000,000 | (Mar 20, 2026)
RunSybil | $40,000,000 | (Mar 20, 2026)
Ezra AI Labs | $3,200,000 | (Mar 20, 2026)
Parallel(FRANCE) | $20,000,000 | (Mar 20, 2026)
Health Universe | $6,000,000 | (Mar 20, 2026)
PADO AI | $6,000,000 | (Mar 20, 2026)
Edra | $30,000,000 | (Mar 20, 2026)
Chalkie AI | $4,000,000 | (Mar 20, 2026)
Deeptune | $43,000,000 | (Mar 20, 2026)